35602-69-8,[(3S,8S,9S,10R,13R,14S,17R)-10,<br />13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,<br />17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadecanoate, Page 2 suppliers

Name: [(3S,8S,9S,10R,13R,14S,17R)-10,
13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,
17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadecanoate
Synonyms: 35602-69-8;[(3S,8S,9S,10R,13R,14S,17R)-10,
13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,
17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadecanoate; 5-Cholesten-3.beta.-ol stearate; Cholesteryl octadecanoate;Cholesteryl stearate; Cholesterol stearate; Cholestryl stearate;
CAS Registry Number:35602-69-8
Melting Point: 79-83 ºC
Density: 0.95 g/cm³
Refractive index: -23 ° (C=2, CHCl3)
Alpha: -21 º (C=2, CHCL3 25 ºC)
Safety Statements: S24/25
EINECS: 252-637-0
Molecular Weight: 653.1155
InchiKey: XHRPOTDGOASDJS-XNTGVSEISA-N
InChI: InChI=1S/C45H80O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)
47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45
(41,6)33-31-42(39)44/h26,35-36,38-42H,7-25,27-34H2,1-6H3/t36-,38+,39+,
40-,41+,42+,44+,45-/m1/s1
Risk Statements: S24/25
Molecular Formula: C₄₅H₈₀O₂
Molecular Structure: